Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma (Q28537688)
Jump to navigation
Jump to search
scientific article (publication date: 2013)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma |
scientific article (publication date: 2013) |
Statements
Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma (English)
0 references
Oliver W Press
Oliver W
Press
1 reference
Lihua E Budde
1 reference
Carolina Berger
1 reference
Yukang Lin
1 reference
Jinjuan Wang
1 reference
Xubin Lin
1 reference
Shani E Frayo
1 reference
Shaunda A Brouns
1 reference
David M Spencer
1 reference
Brian G Till
1 reference
Michael C Jensen
1 reference
Stanley R Riddell
1 reference
2013
0 references
8
0 references
12
0 references
e82742
0 references
17 December 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference